Injection guide · Mitochondrial
How to inject SS-31 (Elamipretide)
A mitochondria-targeting tetrapeptide that binds cardiolipin in the inner mitochondrial membrane. The FDA approved it in September 2025 as FORZINITY, to improve muscle strength in Barth syndrome ; phase 3 trials in primary mitochondrial myopathy and in dry age-related macular degeneration missed their primary endpoints .
01 · Preparation
What you'll need
- Nothing, for the approved product — FORZINITY is supplied as a ready-to-use 80 mg/mL solution and is not reconstituted [8]
- The steps below apply only to research-grade lyophilised SS-31, which has no approved label behind it
- Bacteriostatic water
- Insulin syringes (29-31 gauge)
- Alcohol swabs
Pro tip
Prepare all supplies on a clean surface before you begin. Having everything ready makes the process smoother and more sterile.
02 · Mixing
Reconstitution steps
- Wash your hands thoroughly with soap and water. Gather all supplies on a clean, flat surface.
- Remove the plastic cap from the peptide vial and wipe the rubber stopper with an alcohol swab. Let it air dry.
- Draw the appropriate amount of bacteriostatic water into a sterile syringe.
- Insert the needle into the vial at an angle, aiming at the inside wall of the vial. Slowly push the plunger to let the water trickle down the glass wall -- do NOT squirt directly onto the powder.
- Once all water is added, gently swirl the vial in a slow circular motion. Never shake the vial, as this can damage the peptide bonds.
- Continue swirling until the powder is completely dissolved and the solution is clear. If particles remain, let the vial sit for a few minutes and swirl again.
- Label the vial with the date of reconstitution, the peptide name, and the concentration (e.g. 250mcg per 0.1mL).
Example calculation
FORZINITY needs no calculation: the vial holds 80 mg/mL, so a 40 mg dose is 0.5 mL . For research-grade lyophilised powder, a 50 mg vial reconstituted with 2.5 mL of bacteriostatic water gives 20 mg/mL, so 2 mL (200 units on an insulin syringe) is the 40 mg dose.
Dose calculation
The dose is 40 mg once daily in both cases [8]. From the 80 mg/mL approved solution that is 0.5 mL. From research-grade powder at 20 mg/mL it is 2 mL. The reduced renal dose of 20 mg is 0.25 mL of the approved solution, or 1 mL at 20 mg/mL [8].
Pro tip
Always add the bacteriostatic water slowly, letting it run down the side of the vial. Never shake the vial -- swirl gently to avoid damaging the peptide.
03 · Location
Choosing your injection site
- Site 01AbdomenPinch the skin 2 inches from navel. Avoid the area directly around the belly button. Rotate between left and right sides.
- Site 02Outer ThighMiddle third of the outer thigh. Keep at least 4 inches above the knee and below the hip. Alternate legs each injection.
- Site 03Upper ArmBack or outer area of the upper arm. This site may require assistance from another person for proper technique.
Rotate between 3 sites to prevent tissue buildup and ensure consistent absorption.
Pro tip
Rotate your injection sites with each dose to prevent lipohypertrophy (buildup of fatty tissue). Keep a simple log of where you last injected.
04 · Step by step
Injection technique
- Wash your hands thoroughly with soap and water
- Clean the injection site with an alcohol swab and let it air dry completely
- Pinch about an inch of skin to create a fold of fatty tissue
- Insert the needle at a 45-90 degree angle (45 if lean, 90 if you have more subcutaneous tissue)
- Inject the solution slowly and steadily
- Wait 5-10 seconds before withdrawing the needle
- Apply light pressure with a clean swab if needed—do not rub
Pro tip
This peptide uses subcutaneous injection (just under the skin)—the standard method used in clinical trials with approximately 92% bioavailability. Inject at a 45-90 degree angle into pinched skin. Aspirate before injecting to ensure you haven't hit a blood vessel.
05 · Timing
Your schedule
How often
Once daily
Dose levels, food and stacking notes and a sample day are on the SS-31 (Elamipretide) dosing protocol.
06 · Preservation
Proper storage
Before mixing
The approved product, FORZINITY, is a ready-to-use solution — 280 mg in 3.5 mL (80 mg/mL) in single-patient vials, four to a carton. It needs no reconstitution. Store it refrigerated at 2-8°C and do not freeze it [8]. Research-grade SS-31 is sold instead as a lyophilised powder; keep that refrigerated at 2-8°C in its sealed vial away from light.
After mixing
Once a FORZINITY vial has been opened, it can be kept refrigerated at 2-8°C or at room temperature between 20-25°C, and must be discarded 8 days after first opening [8]. Reconstituted research-grade powder is a different product with no label behind it; refrigerate it, never freeze it, and protect it from light.
Shelf life after mixing
28 days
Signs of degradation
Discard the vial immediately if you notice any of these:
- Cloudiness or haze — the label describes the solution as clear and colourless to yellow [8]
- Visible particles
- Any colour beyond the clear-to-yellow range the label describes [8]
07 · Important
Safety reminders
When to stop
- Any sign of a hypersensitivity reaction — skin or respiratory. The label directs discontinuation for a severe reaction and serious hypersensitivity is its only contraindication [8]
- An injection-site reaction that spreads, worsens, or shows signs of infection. These drove discontinuation in 7.3% of treated participants in phase 3 against 1.8% on placebo [13]
- Your eGFR falling below 30 mL/min — the label halves the dose rather than stopping, but it needs a prescriber's decision [8]
- Your prescriber advises discontinuation
Elamipretide is FDA-approved only to improve muscle strength in Barth syndrome, in patients weighing at least 30 kg, and that approval is an accelerated one pending a confirmatory trial [8][9]. Every other use is investigational. It is a prescription injectable — decisions about starting, stopping or adjusting belong with a prescriber.
Clean technique checklist
- Wash hands thoroughly with soap and water before handling supplies
- Swab vial tops and injection site with alcohol and let dry
- Never touch the needle tip or allow it to contact non-sterile surfaces
- Use a new syringe and needle for each injection
- Dispose of used sharps in a proper sharps container
- Store reconstituted peptides according to the storage instructions above
Continue